A detailed history of Truvestments Capital LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Truvestments Capital LLC holds 50 shares of FLGT stock, worth $1,006. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50
Holding current value
$1,006
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$19.6 - $25.06 $980 - $1,253
50 New
50 $1,000
Q1 2023

May 12, 2023

BUY
$29.39 - $36.27 $117 - $145
4 New
4 $0

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $609M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Truvestments Capital LLC Portfolio

Follow Truvestments Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Truvestments Capital LLC with notifications on news.